NDC11 65862004300
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 65862-0043-0 | 65862-0043 |
| 65862-0043-00 | 65862-0043 |
| 65862-043-00 | 65862-043 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE | Aurobindo Pharma Limited | d7214539-6c3d-466a-a474-6fde096fa182 | 2026-07-21 | Boxed warning, Warnings, Adverse reactions | 65862-043-00 65862-043 65862004300 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.